ROYAL BANK OF CANADA - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 72 filers reported holding AYTU BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$0511
+6.7%
0.00%
Q3 2022$0479
+0.6%
0.00%
Q2 2022$0
-100.0%
4760.0%0.00%
Q1 2022$1,0000.0%476
-6.3%
0.00%
Q4 2021$1,0000.0%508
-13.0%
0.00%
Q3 2021$1,000
-96.6%
584
-89.9%
0.00%
Q2 2021$29,000
+93.3%
5,764
+189.6%
0.00%
Q1 2021$15,000
+1400.0%
1,990
+1050.3%
0.00%
Q4 2020$1,0001730.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Allred Capital Management, LLC 125,000$23,6250.01%
Alyeska Investment Group, L.P. 1,500,000$283,5000.00%
Renaissance Technologies 2,140,782$4050.00%
Affinity Capital Advisors, LLC 11,415$2,1570.00%
FEDERATED HERMES, INC. 4,551$8600.00%
JANE STREET GROUP, LLC 91,887$17,3670.00%
UBS Group AG 5,218$9910.00%
NewEdge Advisors, LLC 435$00.00%
PRUDENTIAL FINANCIAL INC 179,550$33,9350.00%
IFP Advisors, Inc 2,200$150.00%
View complete list of AYTU BIOPHARMA INC shareholders